AGEN: Agenus Inc.
Performance
AGEN +79.65%
Watchlist
Select an item
Summary
AGEN at a glance
AGEN returned +79.65% over the past year and -38.71% a year over five years. Its worst drop in that year was -40.81%, smaller than 36% of stocks on Redstone, and its Sharpe ratio of 0.97 beats 74% of stocks on Redstone. It pays no dividends.
Current Drawdown
-28.00%
Rolling Volatility
83.67%
Actions
Metrics
Risk Indicators
Alpha101.52%
Beta1.51x
Sharpe0.97
Sortino1.89
Omega1.24
Calmar1.95
Martin4.77
Profile
About AGEN
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $323M
- Listed
- Feb 2000
- Employees
- 81
- Headquarters
- Lexington, MA
- Website
- agenusbio.com
Comparisons